Remove 2013 Remove FDA Remove Insurance Remove Insurance Coverage
article thumbnail

Mounjaro vs. Ozempic: Differences, similarities, and side effects

The Checkup by Singlecare

Drug overview & main differences | Conditions treated | Efficacy | Insurance coverage and cost comparison | Side effects | Drug interactions | Warnings | FAQ Mounjaro and Ozempic are two brand-name medications commonly prescribed for the treatment of Type 2 diabetes. Mounjaro Ozempic Typically covered by insurance?

Dosage 52
article thumbnail

A Guide to Getting Birth Control Prescribed by a Pharmacist

BuzzRx

A demanding work and school schedule, family responsibilities, lack of health insurance, and time-consuming doctor appointments are a few obstacles women have to face when getting birth control. However, your health insurance plan may only cover specific brands or their generic versions.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Cymbalta generic availability, cost, and dosage

The Checkup by Singlecare

Food and Drug Administration (FDA) in 2004 , Cymbalta has become a widely used antidepressant to treat various mental health and pain-related conditions. The patent for brand-name Cymbalta expired in 2013, allowing other companies to produce and market duloxetine, the Cymbalta generic name. Approved by the U.S.

Dosage 52
article thumbnail

Top Performing Drug – Enbrel (June Edition)

PharmaShots

The co-promotion collaboration agreement between the two companies in the United States and Canada expired on October 31, 2013. In 2009, Pfizer acquired Wyeth thus seeking the rights to Enbrel.

article thumbnail

10 Facts About Thyroid Disease

The Thyroid Pharmacist

Naltrexone is an FDA-approved medication used for opioid withdrawal at a dose of 50 mg per day. Luckily, even without insurance coverage, this medication is available in generic form and is very affordable, usually costing between $15 to 40 USD per month. 2013 Jan-Feb;19(1):175]. However, low doses of 1.5 Endocr Pract.